AMAlice Michie

Alice Michie

*This is an algorithmically generated author record based on publicly available information.

Alice Michie has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Wastewater-based SARS-CoV-2 surveillance and sequencing

    by Alice Michie

    Though most often associated with poliovirus surveillance, wastewater-based surveillance (WBS) can be employed for viruses shed in human excreta (faeces, urine, skin, sputum, blood) that may enter the wastewater system, including SARS-CoV-2. WBS has been widely adopted during the COVID-19 pandemic, to complement clinical surveillance in monitoring community burden and implementing timely public health interventions. As wastewater is a non-biased, composite sample, it can provide population-level health information in near real-time, in a cost-effective manner compared to similarly scaled clinical surveillance. In many instances, data gathered from wastewater, including viral loads (quantified by RT-qPCR) and variant detections (determined through partial or whole genome sequencing), have been predictive of what is observed eventually in clinical cases. Newly emergent lineages, including the recent BA.2.86 variant, can and have been detected in wastewater samples prior to their detection in clinical specimens. There remain many challenges to wastewater genomic analysis including the presence of RT-qPCR inhibitors, degraded nucleic acid and the lack of consistent or standardised methodology between reporting labs. The wide adoption of WBS practices provides an excellent opportunity to expand this method for surveillance of other pathogens of public health importance. Herein, a broad overview of the WBS field will be provided including discussion on its advantages and applications, challenges, and how it is being utilised to characterise circulating SARS-CoV-2 lineages through sequencing.


  • Open Access

    RAPIDprep: A Simple, Fast Protocol for RNA Metagenomic Sequencing of Clinical Samples

    by Rachel L. Tulloch, Karan Kim, Chisha Sikazwe, Alice Michie, Rebecca Burrell, Edward C. Holmes, Dominic E. Dwyer, Philip N. Britton, Jen Kok, John-Sebastian Eden

    Emerging infectious disease threats require rapid response tools to inform diagnostics, treatment, and outbreak control. RNA-based metagenomics offers this; however, most approaches are time-consuming and laborious. Here, we present a simple and fast protocol, the RAPIDprep assay, with the aim of providing a cause-agnostic laboratory diagnosis of infection within 24 h of sample collection by sequencing ribosomal RNA-depleted total RNA. The method is based on the synthesis and amplification of double-stranded cDNA followed by short-read sequencing, with minimal handling and clean-up steps to improve processing time. The approach was optimized and applied to a range of clinical respiratory samples to demonstrate diagnostic and quantitative performance. Our results showed robust depletion of both human and microbial rRNA, and library amplification across different sample types, qualities, and extraction kits using a single workflow without input nucleic-acid quantification or quality assessment. Furthermore, we demonstrated the genomic yield of both known and undiagnosed pathogens with complete genomes recovered in most cases to inform molecular epidemiological investigations and vaccine design. The RAPIDprep assay is a simple and effective tool, and representative of an important shift toward the integration of modern genomic techniques with infectious disease investigations.


  • Open Access

    RAPIDprep: A Simple, Fast Protocol for RNA Metagenomic Sequencing of Clinical Samples

    by Rachel L Tulloch, Karan Kim, Chisha Sikazwe, Alice Michie, Rebecca Burrell, Edward C. Holmes, Dominic E. Dwyer, Philip N. Britton, Jen Kok, John-Sebastian Eden

    Emerging infectious disease threats require rapid response tools to inform diagnostics, treatment, and outbreak control. RNA-based metagenomics offers this; however, most approaches are time-consuming and laborious. Here, we present a simple and fast protocol – the RAPIDprep assay – with the aim to provide cause agnostic laboratory diagnosis of infection within 24 hours of sample collection by sequencing ribosomal RNA-depleted total RNA. The method is based on the synthesis and amplification of double-stranded cDNA followed by short-read sequencing with minimal handling and clean-up steps to improve processing time. The approach was optimized and applied to a range of clinical respiratory samples to demonstrate diagnostic and quantitative performance. Our results showed robust depletion of both human and microbial rRNA, and library amplification across different sample types, qualities and extraction kits using a single protocol without input nucleic acid quantification or quality assessment. Furthermore, we demonstrate the genomic yield of both known and undiagnosed pathogens with complete genomes recovered in most cases to inform molecular epidemiological investigations and vaccine design. The RAPIDprep assay is a simple and effective tool, and representative of an important shift towards integration of modern genomic techniques to infectious disease investigations.